Octagon Capital Advisors’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30,000	Closed	-$9M	–	50
2024 Q1	$9M	Hold	30,000	–	–	1.08%	25
2023 Q4	$7.08M	Hold	30,000	–	–	1.13%	21
2023 Q3	$4.5M	Hold	30,000	–	–	0.69%	25
2023 Q2	$5.22M	Hold	30,000	–	–	0.73%	27
2023 Q1	$3.78M	Buy	+30,000	New	+$3.78M	0.54%	28